News
News
Poster 2025 ASCO Accepted
05/22/2025
We are delighted that our poster "DeepSeal: Empowering clinical researchers to analyze clinicogenomic data with an intuitive chat-based interface." has been accepted for ASCO 2025…
Read More →
Carl Kingsford Elected 2024 ISCB Fellow
04/13/2024
[Pittsburgh, 03/13/2024] – We are delighted to announce that Dr. Carl Kingsford, Ocean Genomics co-founder and CEO, and Herbert A. Simon Professor of Computer Science…
Read More →
Ocean Genomics and Geneyx to Enrich Genomic Variant Detection
04/13/2024
Our deeply integrated multi-omics analysis of a patient’s DNA and RNA together identifies critical genomic variants missed using DNA alone…
Read More →
Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines
02/16/2023
Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures…
Read More →
News
Poster 2025 ASCO Accepted
05/22/2025
We are delighted that our poster "DeepSeal: Empowering clinical researchers to analyze clinicogenomic data with an intuitive chat-based interface." has been accepted for ASCO 2025…
Read More →
Carl Kingsford Elected 2024 ISCB Fellow
04/13/2024
[Pittsburgh, 03/13/2024] – We are delighted to announce that Dr. Carl Kingsford, Ocean Genomics co-founder and CEO, and Herbert A. Simon Professor of Computer Science…
Read More →
Ocean Genomics and Geneyx to Enrich Genomic Variant Detection
04/13/2024
Our deeply integrated multi-omics analysis of a patient’s DNA and RNA together identifies critical genomic variants missed using DNA alone…
Read More →
Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines
02/16/2023
Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures…
Read More →
News
Poster 2025 ASCO Accepted
05/22/2025
We are delighted that our poster "DeepSeal: Empowering clinical researchers to analyze clinicogenomic data with an intuitive chat-based interface." has been accepted for ASCO 2025…
Read More →
Carl Kingsford Elected 2024 ISCB Fellow
04/13/2024
[Pittsburgh, 03/13/2024] – We are delighted to announce that Dr. Carl Kingsford, Ocean Genomics co-founder and CEO, and Herbert A. Simon Professor of Computer Science…
Read More →
Ocean Genomics and Geneyx to Enrich Genomic Variant Detection
04/13/2024
Our deeply integrated multi-omics analysis of a patient’s DNA and RNA together identifies critical genomic variants missed using DNA alone…
Read More →
Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines
02/16/2023
Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures…
Read More →
Publications
Publications
Publications
Poster
Poster
Poster
ASHG 2024 - Detection of a pathogenic PRKN inversion by a novel DNA-RNA combined analysis of structural variants
ASHG 2024 - Detection of a pathogenic PRKN inversion by a novel DNA-RNA combined analysis of structural variants
11/07/2024
11/07/2024
11/07/2024
Poster
Poster
Poster
WCLC 2024 Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade
WCLC 2024 Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade
09/07/2024
09/07/2024
09/07/2024
Poster
Poster
Poster
ASCO 2023 with Yale Cancer Center – Identifying Molecular Predictors and Immunomodulatory Role of Dual Checkpoint Inhibitors in Small Cell Lung Cancer
ASCO 2023 with Yale Cancer Center – Identifying Molecular Predictors and Immunomodulatory Role of Dual Checkpoint Inhibitors in Small Cell Lung Cancer
06/02/2023
06/02/2023
06/02/2023
Poster
Poster
Poster
AACR 2023 – Transcriptomic Analysis Identifying Novel Expression Biomarkers of Response in Pancreatic Cancer
AACR 2023 – Transcriptomic Analysis Identifying Novel Expression Biomarkers of Response in Pancreatic Cancer
04/14/2023
04/14/2023
04/14/2023
Abstract
Abstract
Abstract
Abstract Accepted to ASCO 2021: Discovering Responder Predictive Markers in mCRC
Abstract Accepted to ASCO 2021: Discovering Responder Predictive Markers in mCRC
06/01/2021
06/01/2021
06/01/2021
Abstract
Abstract
Abstract
Abstract with Samsung Medical Center Accepted to ASCO 2020: Novel Target Discovery in Pembrolizumab-Resistant Gastric Cancer Using a Comprehensive RNA-seq Analysis Pipeline.
Abstract with Samsung Medical Center Accepted to ASCO 2020: Novel Target Discovery in Pembrolizumab-Resistant Gastric Cancer Using a Comprehensive RNA-seq Analysis Pipeline.
05/13/2020
05/13/2020
05/13/2020
Paper
Paper
Paper
Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome
Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome
12/12/2023
12/12/2023
12/12/2023
Paper
Paper
Paper
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells
09/19/2023
09/19/2023
09/19/2023
Publications
See More →
Poster
ASHG 2024 - Detection of a pathogenic PRKN inversion by a novel DNA-RNA combined analysis of structural variants
11/07/2024
See More →
Poster
WCLC 2024 Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade
09/07/2024
See More →
Poster
ASCO 2023 with Yale Cancer Center – Identifying Molecular Predictors and Immunomodulatory Role of Dual Checkpoint Inhibitors in Small Cell Lung Cancer
06/02/2023
See More →
Poster
AACR 2023 – Transcriptomic Analysis Identifying Novel Expression Biomarkers of Response in Pancreatic Cancer
04/14/2023
Abstract
Abstract Accepted to ASCO 2021: Discovering Responder Predictive Markers in mCRC
06/01/2021
See More →
Abstract
Abstract with Samsung Medical Center Accepted to ASCO 2020: Novel Target Discovery in Pembrolizumab-Resistant Gastric Cancer Using a Comprehensive RNA-seq Analysis Pipeline.
05/13/2020
See More →
Paper
Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome
12/12/2023
See More →
Paper
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells
09/19/2023
See More →